Komori
Japan Medical Dynamic Marketing (7600) · InitiativeRestated

Focused Investment in New Product Development and International Marketing

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2024.

4entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20242016: 120162017: 120172018: 020182019: 020192020: 120202021: 020212022: 020222023: 020232024: 12024
Same theme, other companies
Capital allocation policy for deploying retained earnings to invest in business growth and strengthen the management foundationA theme 218 companies write about · 0 as a headwind · 219 as a tailwind

133 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「We will focus investment of retained earnings on developing new products that can meet the needs of sophisticated and specialized medical settings amid the challenging environment surrounding the medical device industry, and on improving our international marketing capabilities.」

    The policy of focusing investment of retained earnings on new product development and improving international marketing capabilities continues.
  2. FY2020RestatedAnnual report

    「We will focus investment of retained earnings on developing new products that can meet the needs of sophisticated and specialized medical settings amid the challenging environment surrounding the medical device industry, and on improving our international marketing capabilities.」

    The policy of focusing investment of retained earnings on new product development and improving international marketing capabilities continues.
  3. FY2017RestatedAnnual report

    「We will focus investment of retained earnings on developing new products that can meet the needs of sophisticated and specialized medical settings amid the challenging environment surrounding the medical device industry, and on improving our international marketing capabilities.」

    The policy of focusing investment of retained earnings on new product development and improving international marketing capabilities has been reiterated.
  4. FY2016First statedAnnual report

    「We will focus investment of retained earnings on developing new products that can meet the needs of sophisticated and specialized medical settings amid the challenging environment surrounding the medical device industry, and on improving our international marketing capabilities.」

    The company explicitly identifies new product development and international marketing as uses of retained earnings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Medical Dynamic Marketing's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Focused Investment in New Product Development and International Marketing | Japan Medical Dynamic Marketing,INC. (7600) | Komori